Closing on Nov. 3: Investor Calendar + Company Spotlight
he Pipeline video in the CPiH Innovation video series. © 2013 Novo Nordisk All rights reserved. 0513-00015950-1 July 2013
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications in...
BioAlliance Pharma SA develops and manufactures drugs for the treatment of cancer and its associated pathologies. Its product offerings comprise...
Novo Nordisk A/S
SIC Code: 2834